Reviva Pharmaceuticals Holdings (RVPH) Preferred Dividend Payments (2018 - 2019)

Reviva Pharmaceuticals Holdings (RVPH) posted Preferred Dividend Payments of $366475.0 for Q2 2019, up 12.33% sequentially from $326260.0 in Q1 2019.

Reviva Pharmaceuticals Holdings (RVPH) Preferred Dividend Payments (2018 - 2019) Analysis & Trends

Reviva Pharmaceuticals Holdings has reported Preferred Dividend Payments for 2 years, with the latest figure at $366475.0 in Q2 2019.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $366475.0 in Q2 2019, while the trailing twelve-month figure through May 2019 was $1.0 million (changed N/A YoY) and the FY2019 annual result came in at $650811.0, changed N/A from the prior year.
Preferred Dividend Payments improved to $366475.0 in Q2 2019 per RVPH's latest filing, from $326260.0 in the prior quarter.
Over five years, Preferred Dividend Payments peaked at $366475.0 in Q2 2019 and troughed at $17937.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Reviva Pharmaceuticals Holdings	6.74 Mn	6.74 Mn	-	-

Download Data